Morris Pollard

Summary

Affiliation: University of Notre Dame
Country: USA

Publications

  1. ncbi request reprint Hormone-refractory prostate cancer in the Lobund-Wistar rat
    Morris Pollard
    Lobund Institute, University of Notre Dame, Notre Dame, IN 46556, USA
    Exp Biol Med (Maywood) 230:520-6. 2005
  2. ncbi request reprint Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model
    Morris Pollard
    Lobund Institute, University of Notre Dame, Notre Dame, Indiana, USA
    Comp Med 56:461-7. 2006
  3. ncbi request reprint Susceptibility of Lobund-Wistar x Copenhagen hybrid rats to autochthonous prostate carcinogenesis
    Mark A Suckow
    Lobund Laboratory, University of Notre Dame, Notre Dame, IN 46556, USA
    Prostate 64:203-8. 2005
  4. ncbi request reprint Fas ligand expression and its correlation with apoptosis and proliferation in Lobund-Wistar prostate carcinomas
    Linda S Gutierrez
    Walther Cancer Center, Notre Dame, IN, USA
    Pathobiology 72:260-8. 2005
  5. ncbi request reprint Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats
    Julie E Heinrich
    University of Notre Dame Biological Sciences, Notre Dame, IN, USA
    Cancer Immunol Immunother 56:725-30. 2007
  6. ncbi request reprint The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice
    Mark A Suckow
    Walther Cancer Center, 400 Freimann Life Science Center, University of Notre Dame, Notre Dame, IN 46556, USA
    Cancer Lett 209:165-9. 2004
  7. ncbi request reprint Prevention of de novo prostate cancer by immunization with tumor-derived vaccines
    Mark A Suckow
    Lobund Institute, University of Notre Dame, 400 Freimann Life Science Center, Notre Dame, IN, 46556, USA
    Cancer Immunol Immunother 54:571-6. 2005
  8. pmc Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium
    Michael Schlicht
    Department of Pathology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA
    BMC Genomics 5:58. 2004
  9. pmc Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X
    Malgorzata Kamocka
    Medical University of Lodz, Lodz, Poland
    Comp Med 58:282-6. 2008

Detail Information

Publications9

  1. ncbi request reprint Hormone-refractory prostate cancer in the Lobund-Wistar rat
    Morris Pollard
    Lobund Institute, University of Notre Dame, Notre Dame, IN 46556, USA
    Exp Biol Med (Maywood) 230:520-6. 2005
    ..Both spontaneous and chemically induced autochthonous HRPC model systems serve as outstanding models for studies on the prevention and therapy of refractory cancer...
  2. ncbi request reprint Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model
    Morris Pollard
    Lobund Institute, University of Notre Dame, Notre Dame, Indiana, USA
    Comp Med 56:461-7. 2006
    ..The accumulated data indicate that soy-based diets are effective in the prevention of prostate cancer...
  3. ncbi request reprint Susceptibility of Lobund-Wistar x Copenhagen hybrid rats to autochthonous prostate carcinogenesis
    Mark A Suckow
    Lobund Laboratory, University of Notre Dame, Notre Dame, IN 46556, USA
    Prostate 64:203-8. 2005
    ..Transplantation of the Dunning R-3327 prostate tumor cell line is a common model of prostate cancer, though the rat strain (Copenhagen) from which the cell line was derived is resistant to spontaneous and chemically induced prostate cancer...
  4. ncbi request reprint Fas ligand expression and its correlation with apoptosis and proliferation in Lobund-Wistar prostate carcinomas
    Linda S Gutierrez
    Walther Cancer Center, Notre Dame, IN, USA
    Pathobiology 72:260-8. 2005
    ..Although FasL expression has been observed in a subset of human prostate carcinomas, this multistage model allowed in vivo evaluation of subclones of malignant cells with a single genetic susceptibility...
  5. ncbi request reprint Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats
    Julie E Heinrich
    University of Notre Dame Biological Sciences, Notre Dame, IN, USA
    Cancer Immunol Immunother 56:725-30. 2007
    ..These results offer the intriguing possibility that the TFD PAIII vaccine is an effective system for the prevention and, possibly, the treatment of prostate cancer...
  6. ncbi request reprint The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice
    Mark A Suckow
    Walther Cancer Center, 400 Freimann Life Science Center, University of Notre Dame, Notre Dame, IN 46556, USA
    Cancer Lett 209:165-9. 2004
    ..Tumors from drug-treated mice were also more dysplastic and invasive than those from untreated mice. These findings have implications for the use of ranolazine in patients with a history of malignant neoplasms or adenomatous polyps...
  7. ncbi request reprint Prevention of de novo prostate cancer by immunization with tumor-derived vaccines
    Mark A Suckow
    Lobund Institute, University of Notre Dame, 400 Freimann Life Science Center, Notre Dame, IN, 46556, USA
    Cancer Immunol Immunother 54:571-6. 2005
    ..These results demonstrate the possibility that prostate cancer can be prevented by immunization with vaccines based on whole tumor-derived vaccines...
  8. pmc Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium
    Michael Schlicht
    Department of Pathology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA
    BMC Genomics 5:58. 2004
    ..This method is made possible through the use of highly controlled spotted cDNA slide production and the use of comparative bioinformatics databases without the use of cross-species slide hybridizations...
  9. pmc Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X
    Malgorzata Kamocka
    Medical University of Lodz, Lodz, Poland
    Comp Med 58:282-6. 2008
    ..An antihuman CP antibody recognized rat CP in an ELISA and inactivated CP activity in a chromogenic assay. Lobund-Wistar prostate tumors may provide a convenient animal model useful in determining the role of CP in cancer development...